FDA approves new heart failure pill from Novartis
David Epstein, the company’s head of pharmaceuticals, told Reuters last week he was talking to healthcare customers about a system under which they would get the drug at a discount, but then pay Novartis more if, as expected, it successfully reduces the need for costly...
Posted On Jul 08 2015